Back to search

University of Southampton

SIP1/ZEB2-induced epithelial mesenchymal transition promotes metastasis and alters chemokine (C-C motif) ligand 5 expression to modulate the tumour microenvironment in colorectal cancer

Abstract

dc:description.abstract

Epithelial mesenchymal transition (EMT) is a critical trans-differentiation program driving cancer metastasis. Patients showing signs of invasive cancer or the presence of distant metastasis have a poor prognosis. Another well-known feature of decreased cancer-associated survival is the lack of anti-cancer immune responses. Thus I hypothesized that the EMT and anti-tumor response could be linked via altered secretion of soluble factors by metastatic cells.<br/><br/>Colorectal cancer (CRC) cell lines and SIP1-inducible DLD cells were grown in DMEM. The induction of the SIP1 gene was carried out using doxycycline for 3 days. The EMT status of the CRC cell lines were assessed by preforming western blotting, immunofluorescence and RT-PCR for EMT biomarkers. Cytokine/chemokine expression in SIP1 inducible DLD cells was analyzed using commercially-available antibody arrays. Validation of the selected chemokine (CCL5) was carried out using sandwich ELISA as well as RT-PCR, with the CCL5 expression level analysed in a panel of CRC cell lines using the same techniques. The CCL5 promoter was then cloned into pGL3. The mechanism of action of ZEB1/2 on the CCL5 promoter was studied by luciferace assay and chromatin immunoprecipitation (ChIP). CCL5 coding region was cloned into pcDNA3.1 and stably transfected into DLD-1 cells. DLD-1 cells over-expressing CCL5/RANTES were injected orthotopically into SCID mice, and metastasis was investigated by immunohistochemistry (IHC). The relationship between infiltrating T lymphocytes (TILs) and the expression of both CCL5/RANTES and SIP1 was studied in 75 CRC patients by IHC and tissue micrroarray.<br/><br/>The results of evaluating EMT status categorised 13 CRC cell lines as epithelial, intermediate epithelial, intermediate mesechymal and mesenchymal. Cytokine/chemokine antibody arrays showed a significant increase in CCL5/RANTES in induced DLD-SIP1 cells. ELISA, multiplex assays and RT-PCR confirmed the increased secretion of CCL5/RANTES in the induced DLDSIP1 cells. The CRC cell line panel showed that the average level of secreted CCL5/RANTES from mesenchymal CRC cells was significantly more than in epithelial cells (639.7 ± 175 vs 107.6 ± 30 pg/ml, respectively; p=0.0075). mRNA expression profiling confirmed this finding from the CRC panel. Promoter studies showed that ZEB1/2 bind to CCL5 promoter, thus activating CCL5 gene expression. No metastatic spread for of DLD-1 cells overexpressing CCL5/RANTES was observed when orthotopically injected into SCID mice.<br/><br/>Our data shows that CCL5/RANTES is up-regulated by EMT-inducing transcription factor SIP1, and mesenchymal (metastatic) CRC cells secrete significantly more CCL5/RANTES compared to epithelial (non-metastatic) cells. Furthermore, abundant secretion of CCL5/RANTES might be a crucial regulator of immune infiltration in CRC, but not a direct inducer of metastasis, and that needs to be futher investigated. Inhibiting CCL5 activity in metastatic CRC may have a therapeutic potential.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Al Saihati, Hajir
Advisor dc:contributor.advisor
  • Bullock, Marc

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Al Saihati, Hajir. SIP1/ZEB2-induced epithelial mesenchymal transition promotes metastasis and alters chemokine (C-C motif) ligand 5 expression to modulate the tumour microenvironment in colorectal cancer. doctoral thesis, University of Southampton, 2016.